Moderna VP says mixing vaccines ‘is feasible’ but warns more clinical data needed

About This Source - CBC News

CBC News is the division of the Canadian Broadcasting Corporation responsible for the news gathering and production of news programs on the corporation’s English-language operations, namely CBC Television, CBC Radio, CBC News Network, and CBC.ca.

CBC News is the largest news broadcaster in Canada. It frequently collaborates with its French-language counterpart, Radio-Canada Info, although the two are organizationally separate.

Recent from CBC News:

  • Military ombudsman demands full independence amid sexual misconduct crisis
  • Former ambassador calls China’s request for human rights inquiry a ‘distraction’
  • Paul Bernardo denied parole for 2nd time
  • CBC News published this video item, entitled “Moderna VP says mixing vaccines ‘is feasible’ but warns more clinical data needed” – below is their description.

    Moderna vice-president and head of infectious disease research Andrea Carfi tells Power & Politics that mixing the AstraZeneca vaccine with an mRNA dose is possible, but there’s not enough data yet to support changing course.

    CBC News YouTube Channel

    Got a comment? Leave your thoughts in the comments section, below. Please note comments are moderated before publication.

    In This Story: AstraZeneca

    AstraZeneca plc/AB (LON: AZN) is a British-Swedish multinational pharmaceutical and biopharmaceutical company with its headquarters in Cambridge, United Kingdom and Södertälje, Sweden. Its R&D is concentrated in Cambridge in United Kingdom, Södertälje in Sweden, and Maryland and Toronto in North America.

    3 Recent Items: AstraZeneca

  • Blood clots ‘less likely’ after second AstraZeneca dose, Sydney on lockdown watch | 9 News Australia
  • What do the new loosened travel restrictions mean for fully-vaccinated Canadians and residents?
  • State premiers frustrated with vaccine rollout | 7.30
  • In This Story: Moderna

    Moderna is an American biotechnology company based in Cambridge, Massachusetts that focuses on drug discovery, drug development, and vaccine technologies based exclusively on messenger RNA.

    CEO: Stéphane Bancel (2011–)

    Stock ticker: (NASDAQ:MRNA)

    5 Recent Items: Moderna

  • What do the new loosened travel restrictions mean for fully-vaccinated Canadians and residents?
  • Mixing COVID-19 mRNA vaccines is safe and effective, experts stress
  • Global National: June 21, 2021 | Canada loosens travel restrictions for fully vaccinated residents
  • Fully vaccinated Canadians can enter country without quarantine starting July 5 | FULL
  • COVID vaccines increasingly tested on children
  • Leave a Comment